Web Results
www.bloomberg.com/opinion/articles/2021-06-21/four-cancer-treatment-developments-worth-celebrating

Jun 21, 2021 ... New data presented at ASCO confirmed the theory in other types of cancer. A year's adjuvant treatment of lung cancer patients with Roche ...

www.abc12.com/2020/12/07/new-immunotherapy-treatment-for-lung-cancer

Dec 7, 2020 ... The patients on atezolizumab survived an average of 20 months, as compared with 13 months for those on chemotherapy. Doctor Herbst, who authored ...

www.fda.gov/news-events/press-announcements/fda-approves-first-targeted-therapy-lung-cancer-mutation-previously-considered-resistant-drug

May 28, 2021 ... Today, the U.S. Food and Drug Administration approved Lumakras (sotorasib) as the first treatment for adult patients with non-small cell ...

www.youtube.com/watch?v=tgtVrutWK-k

A new U.S. Food and Drug Administration-approved drug targets lung cancer that's been resistant to treatment.LEARN MORE:'Nothing looks ...

my.clevelandclinic.org/health/treatments/11582-immunotherapy

Oct 1, 2020 ... Many clinical trials are underway to find new ways to engage the body's immune system to fight cancer. You may receive immunotherapy as a ...

www.cdc.gov/cancer/survivors/patients/treatments.htm

Common Types of Cancer Treatment · Surgery: An operation where doctors cut out tissue with cancer cells. · Chemotherapy: Special medicines that shrink or kill .....

www.nbcnews.com/health/mens-health/new-radiation-therapy-prostate-cancer-reduces-deaths-study-shows-n1269566

Jun 3, 2021 ... Prostate cancer treatment: A new drug, LU-PSMA-617, targets a protein, prostate-specific membrane antigen (PSMA) that is found on most ...

news.ohsu.edu/2021/06/03/targeted-radioligand-improves-survival-in-advanced-prostate-cancer

Jun 3, 2021 ... Cancer researchers say they have established a new, life-extending treatment option for men with prostate cancer that has spread and become ...

ascopost.com/issues/june-3-2021-narratives-special-issue/new-fda-approved-oncology-drugs-and-label-updates-between-may-8-2020-and-may-8-2021

Jun 3, 2021 ... TRILACICLIB (COSELA) was granted approval as the first therapy in its class to reduce the frequency of chemotherapy-induced bone marrow ...

newsroom.uw.edu/news/new-drug-class-gives-hope-some-ovarian-cancer-patients

May 3, 2021 ... Rucaparib is in a relatively new class of drugs - Poly(ADP-ribose) polymerase or PARP inhibitors - which have been approved for therapy in ...

www.komen.org/breast-cancer/metastatic/emerging-areas

Many new treatments for metastatic breast cancer are under study and treatment is improving. Most of these are drug therapies. Findings from clinical trials ...